FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Hangzhou, China

Biotech startups in Hangzhou, China

Updated 16 Nov 2026

Reset
Biotech startups in Hangzhou, China
One-time CSV
  • 129 funded companies, 82 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~hangzhou-zhejiang.csv129 rows × 18 columns
CompanyCityLast roundAmountDate
AusperBioHangzhouSeries C$120.0M2026-08-27
METiS PharmaceuticalsHangzhouSeries D$55.7M2025-08-04
LYNK PharmaceuticalsHangzhouSeries C$16.7M2023-09-21
DXYHangzhouSeries E$500.0M2020-12-29
Prime LifescienceHangzhouSeries A$14.7M2026-06-30
DIAGENSHangzhouSeries C$14.1M2023-12-29
Qihan BiotechHangzhouSeries B$16.0M2023-09-15
Dishi MedicalHangzhouSeries A$13.7M2026-01-19

8 rows of the CSV in 5 of its 18 columns.

129
Startups
$3.7B
Total raised
28
Funded in the last 12 months
$425.3M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

10 of 129
10 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
Prime Lifescience Prime Lifescience develops a big data platform for life sciences research and analysis. Biotech Series A $14.7M 2026-06-30 $44.5M Qiming Venture Partners, Qiji Investment, Ennovation Ventures 11 to 50 2021
Dishi Medical Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. Biotech Series A $13.7M 2026-01-19 $13.7M Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 11 to 50 2021
Levinthal Levinthal uses artificial intelligence for protein design and co-evolution in food safety and medical care. Artificial intelligence Seed $1K 2025-12-09 $1.6M ZhenFund, Kaitai Capital, Pan-Lin Capital +1 1 to 10 2021
Healsun Biopharm Healsun Biopharm provides antibody and recombinant protein CRO and CDMO services. Biotech Series C $27.8M 2025-11-19 $101.3M Yinxinggu Capital, Haitong Capital, Dongfang Jiafu +2 251 to 500 2015
METiS Pharmaceuticals METiS Pharmaceuticals is an AI-driven drug formulation company. Artificial intelligence Series D $55.7M 2025-08-04 $391.7M Source Code Capital, Frees Fund, Luminous Ventures (former Lightspeed China Partners) 51 to 100 2020
DIAGENS DIAGENS is a Hangzhou-based biotechnology firm that provides in-vitro diagnostic products and medical equipment. Biotech Series C $14.1M 2023-12-29 Shenzhen Guozhong Venture Capital Management, Haiyuan Capital, China Venture Capital HRVC +2 51 to 100 2014
LYNK Pharmaceuticals LYNK Pharmaceuticals is a biotech company that discovers and develops new medicines. Biotech Series C $16.7M 2023-09-21 Legend Capital, Kaitai Capital, New Alliance Capital +2 11 to 50 2018
Qihan Biotech Qihan Biotech develops gene-editing technology for organ transplantation. Biotech Series B $16.0M 2023-09-15 $116.3M Matrix Partners China, Northern Light Venture Capital, CMB International Capital Corporation +1 101 to 250 2017
DXY Unicorn DXY is an online healthcare community connecting doctors, consumers, and healthcare organizations. Biotech Series E $500.0M 2020-12-29 $682.0M Shunwei Capital, DCM Ventures, Legend Capital +1 101 to 250 2000

Table 1. Biotech startups in Hangzhou, China: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 129.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
2 Healsun Biopharm Healsun Biopharm provides antibody and recombinant protein CRO and CDMO services. Biotech Series C $27.8M 2025-11-19 $101.3M Yinxinggu Capital, Haitong Capital, Dongfang Jiafu +2 251 to 500 2015
3 Prime Lifescience Prime Lifescience develops a big data platform for life sciences research and analysis. Biotech Series A $14.7M 2026-06-30 $44.5M Qiming Venture Partners, Qiji Investment, Ennovation Ventures 11 to 50 2021
4 Dishi Medical Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. Biotech Series A $13.7M 2026-01-19 $13.7M Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 11 to 50 2021
5 Levinthal Levinthal uses artificial intelligence for protein design and co-evolution in food safety and medical care. Artificial intelligence Seed $1K 2025-12-09 $1.6M ZhenFund, Kaitai Capital, Pan-Lin Capital +1 1 to 10 2021

Table 2. Biotech startups in Hangzhou, China: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Legend Capital Venture capital firm Beijing, China 3 2%
2 Puhua Capital Venture capital firm Hangzhou, China 3 2%
3 Pan-Lin Capital Venture capital firm Shanghai, China 3 2% 1 Levinthal
4 Qiming Venture Partners Venture capital firm Shanghai, China 2 2% 2 AusperBio, Prime Lifescience
5 Source Code Capital Venture capital firm Chaoyang, China 2 2%
6 Kaitai Capital Venture capital firm Hangzhou, China 2 2% 1 Levinthal
7 Lilly Asia Ventures Venture capital firm Shanghai, China 2 2%
8 Qiji Investment Venture capital firm Suzhou, China 2 2% 1 Prime Lifescience
9 Haiyuan Capital Venture capital firm Shenzhen, China 2 2%
10 Matrix Partners China Venture capital firm Beijing, China 2 2%
11 Fortune Venture Capital Venture capital firm Shenzhen, China 2 2% 1 Dishi Medical
12 Xinghua Dingli Venture capital firm 2 2%
13 Yinxinggu Capital Venture capital firm Hangzhou, China 2 2% 1 Healsun Biopharm
14 Prox Ventures Venture capital firm Shanghai, China 2 2%
15 ZhenFund Entrepreneurship program Beijing, China 2 2% 1 Levinthal

Table 3. Biotech startups in Hangzhou, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 108 84% $3.3B
Software 7 5% $1.1B
Artificial intelligence 5 4% $414.6M
Hardware 4 3%
Energy 1 1% $7.4M

Table 4. Biotech startups in Hangzhou, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 42 33% $1.5M
Series A 37 29% $14.1M
Series B 23 18% $16.0M
Series C 20 16% $29.6M
Series D+ 7 5% $47.1M

Table 5. Biotech startups in Hangzhou, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 4%
September 2026 3 11% $16.4M
August 2026 4 14% $163.1M
July 2026 2 7% $21.4M
June 2026 3 11% $59.0M
April 2026 3 11% $23.2M
March 2026 3 11% $21.9M
February 2026 2 7% $28.8M
January 2026 2 7% $20.9M
December 2025 4 14% $42.6M
November 2025 1 4% $27.8M

Table 6. Biotech startups in Hangzhou, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 23 18% $354.9M
2025 28 22% $355.0M
2024 14 11% $73.8M
2023 22 17% $125.4M
2022 11 9% $36.6M
2021 9 7% $625.1M

Table 7. Biotech startups in Hangzhou, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 18 14%
2020 to 2022 36 28%
2015 to 2019 43 34%
2010 to 2014 22 17%
Before 2010 9 7%

Table 8. Biotech startups in Hangzhou, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 8 9%
11 to 50 43 46%
51 to 100 24 26%
101 to 250 13 14%
251 to 500 2 2%
501 to 1,000 2 2%
1,001 to 5,000 1 1%

Table 9. Biotech startups in Hangzhou, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Hangzhou, China are on the list?
129, in the file dated 16 November 2026. 28 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 129 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Hangzhou, China: 129 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Hangzhou, China by funding stage

Other sectors in Hangzhou

Biotech startups elsewhere

Cite: FundingWatcher, 129 funded biotech companies in Hangzhou, China, 16 November 2026. https://fundingwatcher.com/startups/biotech/hangzhou-zhejiang/